Tim Walker
University of Newcastle
27 Papers
84 Citations
Tim Walker is an academic researcher from University of Newcastle. The author has contributed to research in topics: Medicine & Hepatitis B virus. The author has an hindex of 9, co-authored 25 publications. Previous affiliations of Tim Walker include Barwon Health & Geelong Hospital.
Chat about Author
Papers
Health Professional Training and Capacity Strengthening Through International Academic Partnerships: The First Five Years of the Human Resources for Health Program in Rwanda
Corrado Cancedda,Phil Cotton,Joseph Shema,Stephen Rulisa,Robert Riviello,Lisa V. Adams,Paul Farmer,Jeanne Kagwiza,Patrick Kyamanywa,Donatilla Mukamana,Chrispinus H. Mumena,David Tumusiime,Lydie Mukashyaka,Esperance Ndenga,Theogene Twagirumugabe,Kaitesi Batamuliza Mukara,Vincent Dusabejambo,Tim Walker,Tim Walker,Emmy Nkusi,Lisa Bazzett-Matabele,Alex Butera,Belson Rugwizangoga,Jean Claude Kabayiza,Simon Kanyandekwe,Louise Kalisa,Faustin Ntirenganya,Jeffrey Dixson,Tanya Rogo,Natalie McCall,Mark H. Corden,Rex Wong,Madeleine Mukeshimana,Agnes Gatarayiha,Egide Kayonga Ntagungira,Attila Yaman,Juliet Musabeyezu,Anne Sliney,Tej Nuthulaganti,Meredith Kernan,Peter Okwi,Joseph Rhatigan,Jane Barrow,Kim Wilson,Adam C. Levine,Rebecca Reece,Michael Koster,Rachel T Moresky,Jennifer E. O’flaherty,Paul Palumbo,Rashna Ginwalla,Cynthia Binanay,Nathan M. Thielman,Michael V. Relf,Rodney L. Wright,Rodney L. Wright,Mary Hill,Deborah Chyun,Robin Toft Klar,Linda L. McCreary,Tonda L. Hughes,Marik Moen,Valli Meeks,Beth Barrows,Marcel E. Durieux,Craig D. McClain,Amy Bunts,Forrest J. Calland,Bethany Hedt-Gauthier,Danny A. Milner,Danny A. Milner,Giuseppe Raviola,Stacy E. Smith,Meenu Tuteja,Urania Magriples,Asghar Rastegar,Linda Arnold,Ira C. Magaziner,Agnes Binagwaho,Agnes Binagwaho +79 more
TL;DR: Over the next 2 academic years, it is critical for the sustainability of the 22 training programs supported by the HRH Program that the health-related Schools at the CMHS significantly scale up recruitment of new Rwandan faculty.
92
Hepatitis B and C seroprevalence among health care workers in a tertiary hospital in Rwanda
Fredrick Kateera,Tim Walker,Leon Mutesa,Vincent Mutabazi,Emmanuel Musabeyesu,Constance Mukabatsinda,Pascal Bihizimana,Patrick Kyamanywa,Ben Karenzi,Judy Orikiiriza,Judy Orikiiriza +10 more
TL;DR: The low HBV vaccination coverage and poor knowledge of preventative measures among HCWs suggest low levels of viral hepatitis awareness despite this high exposure.
58
Innovative strategies for the elimination of viral hepatitis at a national level: A country case series.
Sophia Schroeder,Sophia Schroeder,Alisa Pedrana,Alisa Pedrana,Nick Scott,David Wilson,David Wilson,Christian Kuschel,Lisa Aufegger,Rifat Atun,Ricardo Baptista-Leite,Ricardo Baptista-Leite,Maia Butsashvili,Manal Elsayed,Aneley Getahun,Saeed Hamid,Radi Hammad,Ellen 't Hoen,Sharon J. Hutchinson,Sharon J. Hutchinson,Jeffrey V. Lazarus,Olufunmilayo A. Lesi,Wangsheng Li,Rosmawati Mohamed,Sigurdur Olafsson,Raquel Peck,Annette H. Sohn,Mark W. Sonderup,C W Spearman,Tracy Swan,Mark Thursz,Tim Walker,Margaret Hellard,Jessica Howell,Jessica Howell,Jessica Howell +35 more
TL;DR: Eight case studies from a diverse range of countries that have invested in responses to viral hepatitis and adopted innovative approaches to tackle their respective epidemics provide models for planning, investment and implementation strategies for other countries facing similar challenges and resource constraints.
Helicobacter pylori status and associated gastroscopic diagnoses in a tertiary hospital endoscopy population in Rwanda.
TL;DR: The overall H. pylori positivity rate was 75% (n=825), similar to that found elsewhere in sub-Saharan Africa, and common endoscopic diagnoses included duodenal ulceration, benign gastric outlet obstruction and malignancy.
35
Efficacy of Helicobacter pylori eradication regimens in Rwanda: a randomized controlled trial.
Jean Damascene Kabakambira,Celestin Hategeka,Cameron Page,Cyprien Ntirenganya,Vincent Dusabejambo,Jules Ndoli,Francois Ngabonziza,Devon C. Hale,Claude Bayingana,Tim Walker +9 more
TL;DR: Clarithromycin and ciprofloxacin based combination therapies are effective and safe to use alternatively for H. pylori eradication and improve HRQoL.